Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Model for End-Stage Liver Disease: End of the First Decade CLINICS IN LIVER DISEASE Asrani, S. K., Kim, W. R. 2011; 15 (4): 685-?

Abstract

The Model for End-stage Liver Disease (MELD) score is the basis for allocation of liver allografts for transplantation in the United States. The MELD score, as an objective scale of disease severity, is also used in the management of patients with chronic liver disease in the nontransplant setting. Several models have been proposed to improve the MELD score. The authors believe that the MELD score is, by design, continually evolving and lends itself to continued refinement and improvement to serve as a metric to optimize organ allocation in the future.

View details for DOI 10.1016/j.cld.2011.08.009

View details for Web of Science ID 000297379100002

View details for PubMedID 22032523

View details for PubMedCentralID PMC3564596